Tue, June 5, 2012
Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012

Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html
Published in Health and Fitness on Tuesday, May 29th 2012 at 16:05 GMT by Market Wire   Print publication without navigation


Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference -- WASHINGTON, May 29, 2012 /PRNewswire-FirstCall/ --

Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

[ ]

Presentation will be Webcast Live and Archived on Vanda's Website

WASHINGTON, May 29, 2012 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: [ VNDA ]), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the Jefferies Global Healthcare Conference in New York City on Monday, June 4, 2012 at 12:30 p.m. Eastern Time.

Dr. Polymeropoulos' presentation at the Jefferies Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, go to Vanda's website at [ http://www.vandapharma.com ] and click on the Presentations tab on the Investor Relations page.  Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit [ http://www.vandapharma.com ].

Company Contact:
Cristina Murphy
Senior Communications Manager
Vanda Pharmaceuticals Inc.
(202) 734-3414
[ cristina.murphy@vandapharma.com ]

SOURCE Vanda Pharmaceuticals Inc.

[ Back to top ]

RELATED LINKS
[ http://www.vandapharma.com ]


Publication Contributing Sources